GlassScriptPhysician profile
Jacqueline Rufo
NPI 1740955400
$554.70
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.88 · 2022: $198 · 2023: $156 · 2024: $41.64 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $133.42 | 2023-2025 | Dupixent |
| Integra Lifesciences Corporation | $126.97 | 2021-2024 | Codman Hakim, Duraseal Exact Spinal Sealant System, Codman Certas |
| Convatec INC. | $81.02 | 2022 | |
| Optinose US, INC. | $41.75 | 2022-2023 | |
| Cochlear Americas | $32.75 | 2023-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Astrazeneca Pharmaceuticals LP | $26.24 | 2025 | Tezspire |
| Hologic Sales and Service, LLC | $22.52 | 2023 | Coolseal Generator |
| Phadia US INC. | $19.86 | 2024 | Immunocap |
| Glaxosmithkline, LLC. | $19.81 | 2022 | |
| Stryker Corporation | $18.12 | 2023 | Audion Et Dilation System, Clarifix Cryotherapy Device |
| Med-El Corporation | $16.62 | 2023 | Mi1250 Synchrony 2 Flexsoft |
| Olympus America INC. | $15.62 | 2023 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Rufo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.